Target intelligence / Profile preview

CD63 antigen (CD63)

Target
CD63
Molecular classification
Tetraspanin family, Transmembrane 4 superfamily, Cell surface glycoprotein
01

Overview

CD63 antigen (CD63) is a member of the tetraspanin family (transmembrane 4 superfamily), characterized by four transmembrane domains and primarily associated with intracellular vesicle membranes, though it can be expressed on the cell surface under certain activation states[1][2]. CD63 interacts with integrins and other membrane proteins, mediating signal transduction events that influence cell development, activation, motility, adhesion, and vesicular transport[1][2]. It is a key marker for activated basophils in allergy diagnostics (basophil activation test), is involved in intracellular trafficking in melanocytes, and has roles as a marker and modulator in cancer (especially melanoma)[1][3]. Deficiency in CD63 is associated with Hermansky-Pudlak syndrome. CD63 is widely used as a lineage, activation, and exosome marker in cell biology and clinical research[1][2].

Other names
CD63 moleculeMLA1TSPAN30LAMP-3Limp1Tspan-30ME491HOP-26Pltgp40AD1GranulophysinLysosomal-associated membrane protein 3Lysosome integral membrane protein 1Melanoma-associated antigen ME491OMA81HOcular melanoma-associated antigenTetraspanin-30AD1 antigengranulophysinlimp1melanoma-associated antigen ME491melanoma-associated antigen MLA1ocular melanoma-associated antigentetraspanin-30tspan-30
02

Mechanism of action

Antibodies: Mark or block CD63 as a cellular activation and lineage marker (e.g., in allergy diagnostics, flow cytometry). Experimental: Potential modulation of integrin and tetraspanin-related signaling pathways via therapeutic antibodies or ligands.

03

Biological functions

Signal transductionCell developmentCell activationCell growthCell motilityIntracellular vesicular transportTrafficking and maturation of melanocytesPlatelet activationLeukocyte adhesion
04

Disease associations

Cancer (tumor progression, melanoma-associated antigen)InflammationInfection (e.g., HIV-1)Hermansky-Pudlak syndrome (deficiency state)Allergy (IgE-mediated)
05

Safety considerations

No direct safety concerns reported for therapies targeting CD63, but as a broadly expressed membrane and vesicle marker, potential off-target effects if targeted therapeutically
06

Interacting drugs

None routinely used in clinical practice. Anti-CD63 antibodies are used in research and diagnostics (e.g., basophil activation test); some investigational therapies are under development targeting CD63-expressing cells, but no major approved drugs are known
07

Biomarkers

Marker of activated basophils (e.g., for basophil activation test in allergy["BAT"])Platelet activation markerMarker for exosomes and multivesicular bodies in cell biologyMarker for certain cancers (e.g., melanoma)

Beyond the preview

Go deeper on CD63 antigen (CD63).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD63 antigen (CD63).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call